top of page

Eliminating Stigma, Discrimination and Criminalisation of Key Populations

Fri, 17 Mar

|

Webinar

This webinar will provide evidence-based insights on stigma and discrimination faced by people living with HIV and key populations; as well as lived experiences of community speakers on how stigma and discrimination affect their quality of life and their access to health services.

Registration is closed
See other events
Eliminating Stigma, Discrimination and Criminalisation of Key Populations
Eliminating Stigma, Discrimination and Criminalisation of Key Populations

Time & Location

17 Mar 2023, 11:00 – 12:30

Webinar

About the event

This webinar will provide evidence-based insights on stigma and discrimination faced by people living with HIV and key populations; as well as lived experiences of community speakers on how stigma and discrimination affect their quality of life and their access to health services. Speakers will discuss how political determinants, such as punitive laws and policies hinder key populations from fully exercising their human rights and living a life free of stigma and discrimination. They will make recommendations on how to improve the current situation, and outline good practices to be considered by different policymakers, healthcare providers, and organisations representing affected communities, health authorities, and funders.

The webinar will contribute to the development of a Joint Statement highlighting good and promising practices that should be scaled up in order to reach the relevant Sustainable Development Goals and other global and regional targets. A draft of the Joint Statement will be shared in the coming weeks for feedback and input.

This webinar will be held in English.

Share this event

HIV and Mental Health Platform
www.eatg.org

Contact us

Interoffices | Avenue des Arts 56-4c, 1000 Brussels, Belgium

General Inquiries: +32 2 626 96 40

Be the first to know! Join the mailing list.

Thanks for subscribing!

The HIV & Mental Health project has been developed by the EATG, and was made possible through a grant from Gilead Sciences Europe Ltd, Merck Sharp and Dohme, and ViiV Healthcare Europe Ltd. . EATG acknowledges that the sponsors had no control or input into the structure or the content of the initiative.

by EATG

bottom of page